Author

Rema Iyer

Sanford Burnham Prebys Medical Discovery Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Aditi Pedgaonkar· 1 shared Alice SoragniiD· 1 shared Anagha J. DeshpandeiD· 1 shared Aniruddha J. DeshpandeiD· 1 shared Darren FinlayiD· 1 shared Gerard L. BrieniD· 1 shared Hiromi I Wetterstein· 1 shared Kristiina VuoriiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aditi Pedgaonkar

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

SUMO2 Inhibition Reverses Aberrant Epigenetic Rewiring Driven by Synovial Sarcoma Fusion Oncoproteins and Impairs Sarcomagenesis

Rema Iyer, Anagha J. Deshpande, Aditi Pedgaonkar, Pramod Akula Bala, Taehee Kim, Gerard L. Brien, Darren Finlay, Kristiina Vuori, Alice Soragni, Hiromi I Wetterstein, Rabi Murad, Aniruddha J. Deshpande

This study identifies SUMO2 as a selective vulnerability in synovial sarcoma, showing that SUMO2 inhibition reverses SS18-SSX-driven gene expression and impairs tumor growth.

The EMBO Journal · Aug 13, 2025Peer-reviewedCancer Biology